News Pfizer could fetch $15bn for consumer health business Pfizer is considering selling its consumer healthcare business in a deal that could be worth around $15 billion.
News Teva sells women's health division to tackle $35bn debts Teva has sold its women’s health business in order to pay off some of its $35 billion in debts built up in acquiring Allergan’s generics business.
News AZ tried to buy Daiichi Sankyo last year - report Trading in shares of Daiichi Sankyo was suspended yesterday.
News Bidders lining up for Teva women's health unit Allergan generics buyout left Teva with $35m debts
News Trump tax reform uncertainty puts biotech M&A on hold Tesaro and Puma are potential takeover targets
News Neuralink unveils trial linking brain implant to robotic arm Neuralink has been given regulatory approval to start a new trial of its brain implant to see if it can be used to control a robotic arm
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
